Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

microRNAs as pharmacological targets in cancer.

Soriano A, Jubierre L, Almazán-Moga A, Molist C, Roma J, de Toledo JS, Gallego S, Segura MF.

Pharmacol Res. 2013 Sep;75:3-14. doi: 10.1016/j.phrs.2013.03.006. Epub 2013 Mar 25. Review.

PMID:
23537752
2.

Targeting microRNAs in cancer: rationale, strategies and challenges.

Garzon R, Marcucci G, Croce CM.

Nat Rev Drug Discov. 2010 Oct;9(10):775-89. doi: 10.1038/nrd3179. Review.

3.

Therapeutic microRNA strategies in human cancer.

Li C, Feng Y, Coukos G, Zhang L.

AAPS J. 2009 Dec;11(4):747-57. doi: 10.1208/s12248-009-9145-9. Epub 2009 Oct 29. Review.

4.

MicroRNAs in personalized cancer therapy.

Sethi S, Ali S, Sethi S, Sarkar FH.

Clin Genet. 2014 Jul;86(1):68-73. doi: 10.1111/cge.12362. Epub 2014 Mar 20. Review.

PMID:
24635652
5.

microRNA Therapeutics in Cancer - An Emerging Concept.

Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA.

EBioMedicine. 2016 Oct;12:34-42. doi: 10.1016/j.ebiom.2016.09.017. Epub 2016 Sep 20. Review.

6.

The therapeutic potential of microRNAs in cancer.

Thorsen SB, Obad S, Jensen NF, Stenvang J, Kauppinen S.

Cancer J. 2012 May-Jun;18(3):275-84. doi: 10.1097/PPO.0b013e318258b5d6.

PMID:
22647365
7.

Breast cancer and microRNAs: therapeutic impact.

Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E.

Breast. 2011 Oct;20 Suppl 3:S63-70. doi: 10.1016/S0960-9776(11)70297-1. Review.

PMID:
22015296
8.

The emerging role of microRNAs in resistance to lung cancer treatments.

MacDonagh L, Gray SG, Finn SP, Cuffe S, O'Byrne KJ, Barr MP.

Cancer Treat Rev. 2015 Feb;41(2):160-9. doi: 10.1016/j.ctrv.2014.12.009. Epub 2014 Dec 23. Review.

PMID:
25592062
9.

MicroRNAs as therapeutic targets in chemoresistance.

Garofalo M, Croce CM.

Drug Resist Updat. 2013 Jul-Nov;16(3-5):47-59. doi: 10.1016/j.drup.2013.05.001. Epub 2013 Jun 10. Review.

10.

miRNA-101: a potential target for tumor therapy.

Gui T, Shen K.

Cancer Epidemiol. 2012 Dec;36(6):537-40. doi: 10.1016/j.canep.2012.05.004. Epub 2012 May 28. Review.

PMID:
22647681
11.

MicroRNA in cancer: new hopes for antineoplastic chemotherapy.

Di Leva G, Briskin D, Croce CM.

Ups J Med Sci. 2012 May;117(2):202-16. doi: 10.3109/03009734.2012.660551. Epub 2012 Feb 21. Review.

12.

MicroRNAs as anti-cancer therapy.

Garofalo M, Leva GD, Croce CM.

Curr Pharm Des. 2014;20(33):5328-35. Review.

PMID:
24479801
13.

miRNAs in human cancer.

Zhong X, Coukos G, Zhang L.

Methods Mol Biol. 2012;822:295-306. doi: 10.1007/978-1-61779-427-8_21.

14.

MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy.

Mognato M, Celotti L.

Mini Rev Med Chem. 2015;15(13):1052-62. Review.

15.

MicroRNAs and cancer therapy - from bystanders to major players.

Braicu C, Calin GA, Berindan-Neagoe I.

Curr Med Chem. 2013;20(29):3561-73. Review.

PMID:
23834177
16.

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Rupaimoole R, Slack FJ.

Nat Rev Drug Discov. 2017 Mar;16(3):203-222. doi: 10.1038/nrd.2016.246. Epub 2017 Feb 17. Review.

PMID:
28209991
17.

Mechanisms of microRNA deregulation in human cancer.

Deng S, Calin GA, Croce CM, Coukos G, Zhang L.

Cell Cycle. 2008 Sep 1;7(17):2643-6. Epub 2008 Sep 12. Review.

PMID:
18719391
18.

miRNA and cancer; computational and experimental approaches.

Tutar Y.

Curr Pharm Biotechnol. 2014;15(5):429.

PMID:
25189575
19.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Review.

PMID:
22975591
20.

miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.

Qian B, Nag SA, Su Y, Voruganti S, Qin JJ, Zhang R, Cho WC.

Curr Cancer Drug Targets. 2013 Jun;13(5):519-41. Review.

PMID:
23597193

Supplemental Content

Support Center